Nifty
Sensex
:
:
23349.90
77155.79
-168.60 (-0.72%)
-422.59 (-0.54%)

Pharmaceuticals & Drugs - Global

Rating :
N/A

BSE: 532331 | NSE: AJANTPHARM

2266.60
05-Jul-2024
  • Open
  • High
  • Low
  • Previous Close
  •  2222.00
  •  2275.80
  •  2160.15
  •  2219.75
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  537594
  •  11935.98
  •  3485.00
  •  1850.25

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 36,700.42
  • 41.70
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 36,637.91
  • 1.74%
  • 9.92

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 66.26%
  • 0.21%
  • 6.71%
  • FII
  • DII
  • Others
  • 9.11%
  • 16.51%
  • 1.20%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 11.07
  • 10.22
  • 8.00

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 8.78
  • 11.39
  • 4.75

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 10.17
  • 11.78
  • 4.62

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 25.75
  • 27.03
  • 28.05

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 5.85
  • 5.78
  • 6.24

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 17.86
  • 18.65
  • 20.13

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Net Sales
1,186.64
1,028.44
15.38%
1,144.92
1,021.04
12.13%
1,054.08
881.84
19.53%
1,105.15
971.77
13.73%
Expenses
875.47
737.78
18.66%
814.57
749.72
8.65%
775.76
732.47
5.91%
791.08
802.22
-1.39%
EBITDA
311.17
290.66
7.06%
330.35
271.32
21.76%
278.32
149.37
86.33%
314.07
169.55
85.24%
EBIDTM
26.22%
28.26%
28.85%
26.57%
26.40%
16.94%
28.42%
17.45%
Other Income
19.48
21.33
-8.67%
26.47
31.75
-16.63%
35.50
36.83
-3.61%
13.59
34.93
-61.09%
Interest
6.02
2.34
157.26%
0.73
0.85
-14.12%
1.53
1.13
35.40%
2.49
2.84
-12.32%
Depreciation
34.39
33.71
2.02%
33.97
33.18
2.38%
34.25
33.02
3.73%
34.26
33.30
2.88%
PBT
290.24
275.94
5.18%
322.12
269.04
19.73%
278.04
152.05
82.86%
290.91
168.34
72.81%
Tax
73.76
80.64
-8.53%
76.35
60.92
25.33%
75.32
29.80
152.75%
80.88
33.83
139.08%
PAT
216.48
195.30
10.84%
245.77
208.12
18.09%
202.72
122.25
65.82%
210.03
134.51
56.14%
PATM
18.24%
18.99%
21.47%
20.38%
19.23%
13.86%
19.00%
13.84%
EPS
17.27
15.46
11.71%
19.61
16.47
19.06%
16.04
9.68
65.70%
16.62
10.46
58.89%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Net Sales
4,490.79
4,208.71
3,742.64
3,340.99
2,889.69
2,587.87
2,055.37
2,125.76
1,983.26
1,733.98
1,473.56
Net Sales Growth
15.06%
12.45%
12.02%
15.62%
11.66%
25.91%
-3.31%
7.19%
14.38%
17.67%
 
Cost Of Goods Sold
1,088.08
880.13
869.31
677.73
514.99
537.75
295.72
317.35
322.58
317.33
290.33
Gross Profit
3,402.71
3,328.58
2,873.33
2,663.26
2,374.70
2,050.12
1,759.65
1,808.41
1,660.68
1,416.65
1,183.23
GP Margin
75.77%
79.09%
76.77%
79.71%
82.18%
79.22%
85.61%
85.07%
83.73%
81.70%
80.30%
Total Expenditure
3,256.88
3,036.77
2,959.39
2,411.70
1,891.13
1,904.55
1,488.94
1,467.37
1,296.38
1,146.92
968.33
Power & Fuel Cost
-
66.57
65.71
54.38
43.70
38.88
32.65
27.42
18.70
15.49
12.91
% Of Sales
-
1.58%
1.76%
1.63%
1.51%
1.50%
1.59%
1.29%
0.94%
0.89%
0.88%
Employee Cost
-
900.34
785.14
645.78
548.25
485.59
430.71
376.47
295.42
256.64
200.58
% Of Sales
-
21.39%
20.98%
19.33%
18.97%
18.76%
20.96%
17.71%
14.90%
14.80%
13.61%
Manufacturing Exp.
-
303.29
320.81
275.42
226.20
204.81
174.78
215.80
192.70
174.40
130.81
% Of Sales
-
7.21%
8.57%
8.24%
7.83%
7.91%
8.50%
10.15%
9.72%
10.06%
8.88%
General & Admin Exp.
-
382.26
365.86
300.83
131.64
159.49
149.90
131.92
92.02
66.24
50.99
% Of Sales
-
9.08%
9.78%
9.00%
4.56%
6.16%
7.29%
6.21%
4.64%
3.82%
3.46%
Selling & Distn. Exp.
-
417.54
463.94
400.29
374.73
413.70
320.99
306.30
270.92
245.92
233.96
% Of Sales
-
9.92%
12.40%
11.98%
12.97%
15.99%
15.62%
14.41%
13.66%
14.18%
15.88%
Miscellaneous Exp.
-
86.64
88.62
57.27
51.62
64.33
84.19
92.11
104.04
70.90
233.96
% Of Sales
-
2.06%
2.37%
1.71%
1.79%
2.49%
4.10%
4.33%
5.25%
4.09%
3.31%
EBITDA
1,233.91
1,171.94
783.25
929.29
998.56
683.32
566.43
658.39
686.88
587.06
505.23
EBITDA Margin
27.48%
27.85%
20.93%
27.81%
34.56%
26.40%
27.56%
30.97%
34.63%
33.86%
34.29%
Other Income
95.04
84.60
98.64
115.68
25.98
92.19
21.08
24.16
23.86
21.15
16.80
Interest
10.77
7.21
5.84
10.20
8.27
11.91
1.16
0.41
1.36
4.89
5.92
Depreciation
136.87
135.40
130.80
125.29
116.09
95.71
72.08
59.59
61.21
44.43
51.64
PBT
1,181.31
1,113.93
745.25
909.48
900.18
667.89
514.27
622.55
648.17
558.89
464.47
Tax
306.31
297.76
157.27
196.80
246.31
196.27
127.30
153.91
141.34
143.28
146.15
Tax Rate
25.93%
26.73%
21.10%
21.64%
27.36%
29.56%
24.75%
24.72%
21.81%
25.64%
32.05%
PAT
875.00
816.17
587.98
712.68
653.87
467.70
386.97
468.64
506.83
415.61
309.86
PAT before Minority Interest
875.00
816.17
587.98
712.68
653.87
467.70
386.97
468.64
506.83
415.61
309.86
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
19.48%
19.39%
15.71%
21.33%
22.63%
18.07%
18.83%
22.05%
25.56%
23.97%
21.03%
PAT Growth
32.54%
38.81%
-17.50%
8.99%
39.81%
20.86%
-17.43%
-7.54%
21.95%
34.13%
 
EPS
70.06
65.35
47.08
57.06
52.35
37.45
30.98
37.52
40.58
33.28
24.81

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Shareholder's Funds
3,567.36
3,387.99
3,264.34
2,995.63
2,598.87
2,245.21
2,041.37
1,567.69
1,190.86
841.09
Share Capital
25.27
25.27
17.17
17.39
17.54
17.54
17.69
17.69
17.69
17.68
Total Reserves
3,536.44
3,362.38
3,246.87
2,977.70
2,580.86
2,226.57
2,022.05
1,550.00
1,173.17
822.98
Non-Current Liabilities
40.82
177.38
285.02
274.55
227.61
162.23
38.56
8.90
28.63
55.67
Secured Loans
0.00
1.25
1.64
1.60
0.74
0.66
1.01
1.04
5.79
23.31
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
9.08
9.94
Long Term Provisions
39.54
146.55
216.04
208.12
155.01
134.15
13.16
4.88
2.59
4.76
Current Liabilities
895.25
1,139.28
647.39
838.82
745.53
498.35
346.05
246.66
259.89
249.59
Trade Payables
463.20
422.77
327.17
373.86
362.34
225.18
249.63
178.18
145.57
109.06
Other Current Liabilities
369.52
669.42
301.47
214.14
180.12
111.45
63.95
46.33
56.72
58.33
Short Term Borrowings
0.00
0.00
0.00
0.00
42.85
33.34
0.00
0.00
46.25
17.90
Short Term Provisions
62.53
47.09
18.75
250.82
160.22
128.38
32.47
22.15
11.35
64.30
Total Liabilities
4,503.43
4,704.65
4,196.75
4,109.00
3,572.01
2,905.79
2,425.98
1,823.25
1,479.38
1,146.35
Net Block
1,479.19
1,496.44
1,503.58
1,541.11
1,472.14
1,168.35
1,052.66
589.17
450.74
288.09
Gross Block
2,389.41
2,282.82
2,206.86
2,140.80
1,976.15
1,578.96
1,417.23
894.94
715.73
549.85
Accumulated Depreciation
910.22
786.38
703.28
599.69
504.01
410.61
364.57
305.77
264.99
261.76
Non Current Assets
1,773.02
1,870.65
1,932.29
1,891.22
1,790.94
1,605.27
1,202.36
972.65
716.11
512.94
Capital Work in Progress
256.45
209.47
152.86
108.19
131.86
261.61
61.33
254.22
198.91
170.20
Non Current Investment
18.58
25.10
25.10
0.00
12.28
22.87
7.58
0.00
0.00
40.04
Long Term Loans & Adv.
14.43
134.79
236.46
230.74
164.20
148.36
76.79
41.88
21.29
9.34
Other Non Current Assets
4.37
4.85
5.88
11.18
10.46
4.08
4.00
2.34
4.28
5.27
Current Assets
2,722.07
2,825.18
2,264.46
2,217.78
1,781.07
1,300.52
1,223.62
850.60
763.27
633.41
Current Investments
330.05
510.27
121.86
175.67
67.14
64.74
182.38
181.56
76.78
19.46
Inventories
828.36
815.63
791.07
766.47
495.68
435.71
350.63
211.02
204.58
159.03
Sundry Debtors
1,246.84
1,056.90
1,019.81
738.43
775.30
459.48
459.79
323.15
372.35
258.76
Cash & Bank
130.77
330.90
211.79
209.61
205.25
100.51
93.09
69.95
43.37
136.76
Other Current Assets
186.05
22.09
34.79
104.15
237.70
240.08
137.73
64.92
66.19
59.40
Short Term Loans & Adv.
132.29
89.39
85.14
223.45
168.68
143.45
23.11
56.29
59.39
47.43
Net Current Assets
1,826.82
1,685.90
1,617.07
1,378.96
1,035.54
802.17
877.57
603.94
503.38
383.82
Total Assets
4,495.09
4,695.83
4,196.75
4,109.00
3,572.01
2,905.79
2,425.98
1,823.25
1,479.38
1,146.35

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Cash From Operating Activity
785.07
792.11
561.71
576.31
456.77
374.51
281.12
609.29
326.14
279.42
PBT
1,113.93
745.25
909.48
900.18
663.97
514.27
622.56
648.17
558.90
456.01
Adjustment
83.03
131.30
91.75
115.27
70.79
61.93
52.48
86.33
53.07
51.21
Changes in Working Capital
-99.76
66.85
-200.39
-208.75
-123.16
-83.46
-254.32
25.88
-124.34
-81.69
Cash after chg. in Working capital
1,097.20
943.40
800.84
806.70
611.60
492.74
420.72
760.38
487.63
425.53
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-312.13
-151.29
-239.13
-230.39
-154.83
-118.23
-139.60
-151.09
-161.49
-146.11
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
65.39
-559.60
-74.10
-282.38
-224.40
-222.78
-256.11
-383.12
-209.07
-158.36
Net Fixed Assets
-156.03
-150.65
-110.38
-137.02
-255.91
-361.08
-327.21
-235.38
-197.00
-138.00
Net Investments
186.12
-388.41
-7.97
-71.11
7.11
107.76
-1.82
-104.79
-17.41
2.22
Others
35.30
-20.54
44.25
-74.25
24.40
30.54
72.92
-42.95
5.34
-22.58
Cash from Financing Activity
-1,051.06
-108.20
-459.71
-318.29
-128.63
-147.46
-0.20
-201.77
-117.32
-105.19
Net Cash Inflow / Outflow
-200.60
124.31
27.90
-24.36
103.74
4.27
24.81
24.40
-0.25
15.87
Opening Cash & Equivalents
329.83
206.36
177.51
202.35
95.16
90.64
65.83
41.42
41.67
38.62
Closing Cash & Equivalent
129.23
330.67
205.41
177.99
198.90
94.91
90.64
65.82
41.42
54.49

Financial Ratios

Consolidated /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Book Value (Rs.)
282.89
269.07
254.80
230.83
297.80
257.19
231.78
178.14
135.31
95.57
ROA
17.73%
13.21%
17.16%
17.03%
14.44%
14.52%
22.06%
30.69%
31.66%
29.57%
ROE
23.49%
17.68%
22.77%
23.38%
19.32%
18.07%
25.98%
36.75%
40.92%
43.24%
ROCE
32.22%
22.57%
29.37%
32.20%
27.44%
23.84%
34.49%
45.74%
51.61%
56.43%
Fixed Asset Turnover
3.42
3.19
1.56
1.43
1.46
1.37
1.84
2.49
2.76
2.85
Receivable days
52.69
52.87
94.50
93.66
87.08
81.62
67.06
63.41
65.84
56.64
Inventory Days
37.60
40.91
83.71
78.09
65.68
69.82
48.10
37.89
37.93
38.64
Payable days
183.71
157.44
188.77
260.89
59.55
63.24
57.26
50.30
41.91
46.38
Cash Conversion Cycle
-93.41
-63.66
-10.56
-89.14
93.21
88.21
57.90
51.01
61.86
48.91
Total Debt/Equity
0.00
0.00
0.00
0.00
0.02
0.02
0.00
0.00
0.07
0.09
Interest Cover
155.50
128.61
90.16
109.85
56.75
444.34
1519.41
477.60
115.29
78.03

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.